Copyright
©The Author(s) 2019.
World J Hepatol. May 27, 2019; 11(5): 450-463
Published online May 27, 2019. doi: 10.4254/wjh.v11.i5.450
Published online May 27, 2019. doi: 10.4254/wjh.v11.i5.450
Etiology | Genetic defect | Manifestations |
FIC1 deficiency | ATP8B1 | BRIC1 |
ICP1 and contraceptive-induced cholestasis | ||
Cryptogenic cirrhosis | ||
BSEP deficiency | ABCB11 | BRIC2 |
ICP2 and contraceptive-induced cholestasis | ||
DILI | ||
Cryptogenic cirrhosis | ||
MDR3 deficiency | ABCB4 | ICP3 and contraceptive-induced cholestasis |
Drug induced cholestasis | ||
Low phospholipid-associated cholestasis | ||
Cholesterol gallstone disease | ||
Biliary fibrosis or liver cirrhosis without cholestasis | ||
Cryptogenic cirrhosis | ||
TJP2 deficiency | TJP2 | Cryptogenic cirrhosis |
FXR | NR1H4 | ICP |
Drug induced cholestasis associated with propylthiouracil |
- Citation: Henkel SA, Squires JH, Ayers M, Ganoza A, Mckiernan P, Squires JE. Expanding etiology of progressive familial intrahepatic cholestasis. World J Hepatol 2019; 11(5): 450-463
- URL: https://www.wjgnet.com/1948-5182/full/v11/i5/450.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i5.450